Regulatory Compliance Associates Inc, a life sciences consultancy focused on quality, regulatory, and technical consulting, has named Neil Pankau as its new executive vice president, Pharmaceuticals, it was reported yesterday.
Pankau brings to his role at RCA more than 25 years of legal, compliance and business experience across regulated industries including pharmaceuticals, biologics, medical devices and dietary supplements. Prior to joining RCA, Pankau held senior leadership positions, including chief compliance officer, in multiple organisations including Getinge AB, Baxter International and Walgreens. He earned his Juris Doctor degree from Marquette University School of Law.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer